Authors
Dale Porter, PhD, is the vice president, head of US oncology and immuno-oncology research at Servier, a global pharmaceutical group with a long-term approach to drug discovery and oncology research and development.
Patricia Hayes, MD, is an internal medicine physician and Texas Area Medical Director for CenterWell.
Robert Pittman is senior vice president of government affairs at Modivcare, a technology-enabled health care services company that provides a platform of integrated supportive care solutions.
Jay Anders, MD, has been chief medical officer at Medicomp Systems since August of 2014.
Advertisement
Advertisement
Trending on AJMC
1
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
2
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
3
Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered
4
Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD
5


